期刊
NATURE REVIEWS CANCER
卷 12, 期 2, 页码 89-103出版社
NATURE PORTFOLIO
DOI: 10.1038/nrc3205
关键词
-
类别
资金
- EU
- Jay and Betty Van Andel Foundation
- Medical Research Council [G0800025] Funding Source: researchfish
- MRC [G0800025] Funding Source: UKRI
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of cancer. Genetic and biochemical data have demonstrated that the growth and motility factor hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, the tyrosine kinase MET, have a causal role in all of these processes, thus providing a strong rationale for targeting these molecules in cancer. Parallel progress in understanding the structure and function of HGF/SF, MET and associated signalling components has led to the successful development of blocking antibodies and a large number of small-molecule MET kinase inhibitors. In this Review, we discuss these advances, as well as results from recent clinical studies that demonstrate that inhibiting MET signalling in several types of solid human tumours has major therapeutic value.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据